info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Binimetinib
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Binimetinib treats melanoma by stopping cancer cells from growing. Melanoma is an invasive form of skin cancer. This medication comes as a tablet that you can take by mouth with a glass of water as directed.N-Nitroso Binimetinib is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Binimetinib CAS NO:NA chemically represented as 5-((4-Bromo-2-fluorophenyl)(nitroso)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide. Synchemia is the leading manufacturing and exporter of N-Nitroso Binimetinib . We supply N-Nitroso Binimetinib with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143476 |
| CAS No | NA |
| Mol.F. | C25H38N4O9 |
| Mol.Wt. | 538.60 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143477 |
| CAS No | NA |
| Mol.F. | C7H14N4O3 |
| Mol.Wt. | 202.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143478 |
| CAS No | NA |
| Mol.F. | C25H36N4O9 |
| Mol.Wt. | 536.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143479 |
| CAS No | NA |
| Mol.F. | C20H30N4O7 |
| Mol.Wt. | 438.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143480 |
| CAS No | NA |
| Mol.F. | C21H34N4O7S |
| Mol.Wt. | 486.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143481 |
| CAS No | NA |
| Mol.F. | C10H10N2O6 |
| Mol.Wt. | 254.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143482 |
| CAS No | NA |
| Mol.F. | C12H14N2O6 |
| Mol.Wt. | 282.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143483 |
| CAS No | NA |
| Mol.F. | C25H29N3O8 |
| Mol.Wt. | 499.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143484 |
| CAS No | NA |
| Mol.F. | C27H39N3O8 |
| Mol.Wt. | 533.62 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143485 |
| CAS No | NA |
| Mol.F. | C15H20N2O5 |
| Mol.Wt. | 308.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143486 |
| CAS No | NA |
| Mol.F. | C26H31N3O8 |
| Mol.Wt. | 513.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143487 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.29 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143488 |
| CAS No | NA |
| Mol.F. | C16H26N2O3 |
| Mol.Wt. | 294.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143489 |
| CAS No | NA |
| Mol.F. | C9H12N4O2S |
| Mol.Wt. | 240.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143490 |
| CAS No | NA |
| Mol.F. | C13H20N4O2S |
| Mol.Wt. | 296.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143491 |
| CAS No | NA |
| Mol.F. | C14H17N5O |
| Mol.Wt. | 271.3 g/mole |
| INV STATUS | In Stock |
